538 related articles for article (PubMed ID: 30029203)
1. Cancer stem cell in breast cancer therapeutic resistance.
Bai X; Ni J; Beretov J; Graham P; Li Y
Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
Chiotaki R; Polioudaki H; Theodoropoulos PA
Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stem cells.
Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
[TBL] [Abstract][Full Text] [Related]
5. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
6. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
Chen W; Zhang L; Liu S; Chen C
Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
[TBL] [Abstract][Full Text] [Related]
7. Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion.
Ojo D; Wei F; Liu Y; Wang E; Zhang H; Lin X; Wong N; Bane A; Tang D
Curr Med Chem; 2015; 22(19):2360-74. PubMed ID: 25882671
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cell: the roles and therapeutic implications.
Yang F; Xu J; Tang L; Guan X
Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
[TBL] [Abstract][Full Text] [Related]
9. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
Semenza GL
Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
[TBL] [Abstract][Full Text] [Related]
12. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
[TBL] [Abstract][Full Text] [Related]
13. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
Zhang R; Tu J; Liu S
Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
Xiang L; Semenza GL
Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
[TBL] [Abstract][Full Text] [Related]
17. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract][Full Text] [Related]
18. The Breast Cancer Stem Cells Traits and Drug Resistance.
Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
[TBL] [Abstract][Full Text] [Related]
19. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
